These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1355 related items for PubMed ID: 18357358

  • 1. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM.
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [Abstract] [Full Text] [Related]

  • 2. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB, Brianzoni MF, Garritani MS, Antonicelli L, Farabollini B, Bonifazi F.
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [Abstract] [Full Text] [Related]

  • 3. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L, Chelminska M, Kuziemski K, Skrzypski M, Niedoszytko M, Damps-Konstanska I, Szymanowska A, Siemińska A, Wajda B, Drozdowska A, Jutel M, Jassem E.
    Int Arch Allergy Immunol; 2008 Dec; 147(3):241-5. PubMed ID: 18594155
    [Abstract] [Full Text] [Related]

  • 4. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A, Confino-Cohen R.
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [Abstract] [Full Text] [Related]

  • 5. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 6. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D, Nucera E, Pollastrini E, De Pasquale T, Buonomo A, Bartolozzi F, Lombardo C, Roncallo C, Patriarca G.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [Abstract] [Full Text] [Related]

  • 7. Adverse reactions to venom immunotherapy.
    Ramirez DA, Londono S, Evans R.
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [Abstract] [Full Text] [Related]

  • 8. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X, Ledent C, Mairesse M.
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F, Wenderoth A, Przybilla B.
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [Abstract] [Full Text] [Related]

  • 11. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S, Przybilla B, Dugas M, Arnold A, Pfundstein G, Küchenhoff H, Ruëff F.
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [Abstract] [Full Text] [Related]

  • 12. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, Mozafari H, Mohammadzadeh I, Chavoshzadeh Z, Shirkhoda Z.
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [Abstract] [Full Text] [Related]

  • 13. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Dec; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 14. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B, Ring J, Griesshammer B, Braun-Falco O.
    Dtsch Med Wochenschr; 1987 Mar 13; 112(11):416-24. PubMed ID: 3816590
    [Abstract] [Full Text] [Related]

  • 15. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL.
    Ann Allergy; 1994 Nov 13; 73(5):423-8. PubMed ID: 7978535
    [Abstract] [Full Text] [Related]

  • 16. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb 13; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 17. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Feb 13; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 18. Case report of venom immunotherapy for a patient with large local reactions.
    Hamilton RG, Golden DB, Kagey-Sobotka A, Lichtenstein LM.
    Ann Allergy Asthma Immunol; 2001 Aug 13; 87(2):134-7. PubMed ID: 11527245
    [Abstract] [Full Text] [Related]

  • 19. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE.
    Clin Exp Allergy; 2008 Feb 13; 38(2):291-7. PubMed ID: 18070166
    [Abstract] [Full Text] [Related]

  • 20. Hymenoptera stings.
    Fitzgerald KT, Flood AA.
    Clin Tech Small Anim Pract; 2006 Nov 13; 21(4):194-204. PubMed ID: 17265905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.